SCIENCE WITH A SENSE OF PURPOSE
Tomorrow’s
breakthroughs.
Today’s urgency.
Advancing neuroendocrine cancer research.
Because the future of treatment can’t wait.
Accelerating Discovery. Advancing Treatment. Pursuing a Cure.
THE REASON WE EXIST
Patients live on
a different clock.
Scientific progress should move with the urgency of the people who need it.
We are building a research-focused philanthropic initiative to connect scientific ambition with patient urgency. Our purpose is to help promising neuroendocrine cancer research move toward more effective treatments—and, ultimately, a cure.
That means bringing researchers, physicians, biotechnology innovators, and philanthropic supporters into the same conversation.
The mission behind the instituteOUR SCIENTIFIC HORIZON
Big questions.
Promising directions.
Where scientific rigor meets the possibility of meaningful clinical impact.
Explore all research interestsHistotripsy & tumor ablation
Exploring what local treatment could make possible.
Clinical application · investigational immune effectsImmunotherapy & the microenvironment
Investigating the barriers to an immune response.
Early clinical & preclinical researchTargeted radionuclide therapy
Pursuing more precise ways to deliver treatment.
Established PRRT · emerging approachesProspective research interests. These are not currently funded institute programs. Investigational approaches require rigorous evaluation.
A PERSONAL CATALYST. A SHARED MISSION.
Built from resolve.
Driven by possibility.
Entrepreneur Sean Bassik founded this initiative to bring the determination of a builder to one of medicine’s most pressing challenges: accelerating progress against neuroendocrine cancer.
His vision is grounded in a simple conviction—credible ideas deserve the resources and collaboration needed to move forward.
Meet our founder & leadershipINSIGHTS & DISCOVERIES
A clearer view of
the science ahead.
Histotripsy: evidence and possibility
Where local tumor treatment ends, and the question of systemic immunity begins.
Read the perspectivePRRT: progress and the next questions
An established treatment platform—and a foundation for more precise, durable therapies.
Read the perspectivePrecision research starts with better questions
Why tumor biology, clear evidence, and well-designed trials must guide the search for new treatments.
Read the perspective